Fergus Keane

12PUBLICATIONS
84CO-AUTHORS
Molecular targetsCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 27, 2026
POLQ-driven repair scars shape the immunogenic landscape of homologous recombination-deficient pancreatic cancer.

Wungki Park, Shigeaki Umeda, Marc Hilmi

|Feb 04, 2026
National Trends in Early-Onset Colorectal Cancer: Incidence and Challenges in the Republic of Ireland.

Mary O'Reilly, Aleksandar Krstic, Luis F Iglesias-Martinez

|Oct 30, 2025
Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.

Celine Yeh, Oliver Artz, Haochen Zhang

|Oct 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort.

Fergus Keane, Catherine O'Connor, Drew Moss

|May 03, 2024
Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease.

Fergus Keane, Joanne F Chou, Henry Walch

|Mar 19, 2024
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer.

Emily Harrold, Fergus Keane, Henry Walch

Pageof 2

Frequent Collaborators

7 joint publications

Wungki Park

6 joint publications

Eileen M O'Reilly

3 joint publications

Catherine O'Connor

3 joint publications

Chaitanya Bandlamudi